Moreover, further studies will focus on validating the diagnostic accuracies of another four non-validated potential biomarkers (HBB, TXNRD1, CAKP5, GSPT2) and on analyzing the relationships between the expressed levels of those biomarkers and the prognosis of GC patients. The gene discussed is TXNRD1; the disease is gastric cancer.